Etretinate and visual function: a 1-year follow-up study.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 1873203.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Concern has been expressed in the literature that the drug etretinate may be potentially retinotoxic. Four patients are reported who have received long-term treatment with etretinate and who have undergone detailed evaluation for the development of visual dysfunction over a 1-year period. Despite prolonged treatment and high total doses no evidence of ocular toxicity attributable to the drug was found in any of the patients.
Medical subject headings
- Etretinate
- Vision Disorders